In breast cancer, promoter CpG island hypermethylation has been described for genes involved in all aspects of cellular function and was found to be associated with various histopathologic characteristics, including tumor grade [5], [6], hormone receptor [7], [8], HER2/neu status [9] and molecular subtype [10]–[13]. The gene discussed is ERBB2; the disease is breast cancer.